Gensight Biologics SA
PAR:SIGHT

Watchlist Manager

Gensight Biologics SA

PAR:SIGHT

Watchlist

Dividends

Discount Rate

Price: 0.315 EUR -1.1% Market Closed

Market Cap: 36.3m EUR

Have any thoughts about
Gensight Biologics SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 0.315 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

SIGHT Alert

Gensight Biologics SA

0.315

-0.0035 (-1.1%)

52 Week Range	0.2815 0.522
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Gensight Biologics SA

What unique competitive advantages
does Gensight Biologics SA hold over its rivals?

What risks and challenges
does Gensight Biologics SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Gensight Biologics SA.

What unique competitive advantages
does Gensight Biologics SA hold over its rivals?

What risks and challenges
does Gensight Biologics SA face in the near future?

Has there been any significant insider trading activity
in Gensight Biologics SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Gensight Biologics SA.

Provide P/S
for Gensight Biologics SA.

Provide P/E
for Gensight Biologics SA.

Provide P/OCF
for Gensight Biologics SA.

Provide P/FCFE
for Gensight Biologics SA.

Provide P/B
for Gensight Biologics SA.

Provide EV/S
for Gensight Biologics SA.

Provide EV/GP
for Gensight Biologics SA.

Provide EV/EBITDA
for Gensight Biologics SA.

Provide EV/EBIT
for Gensight Biologics SA.

Provide EV/OCF
for Gensight Biologics SA.

Provide EV/FCFF
for Gensight Biologics SA.

Provide EV/IC
for Gensight Biologics SA.

Show me price targets
for Gensight Biologics SA made by professional analysts.

What are the Revenue projections
for Gensight Biologics SA?

How accurate were the past Revenue estimates
for Gensight Biologics SA?

What are the Net Income projections
for Gensight Biologics SA?

How accurate were the past Net Income estimates
for Gensight Biologics SA?

What are the EPS projections
for Gensight Biologics SA?

How accurate were the past EPS estimates
for Gensight Biologics SA?

What are the EBIT projections
for Gensight Biologics SA?

How accurate were the past EBIT estimates
for Gensight Biologics SA?

Compare the revenue forecasts
for Gensight Biologics SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Gensight Biologics SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Gensight Biologics SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Gensight Biologics SA compared to its peers.

Compare the P/E ratios
of Gensight Biologics SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Gensight Biologics SA with its peers.

Analyze the financial leverage
of Gensight Biologics SA compared to its main competitors.

Show all profitability ratios
for Gensight Biologics SA.

Provide ROE
for Gensight Biologics SA.

Provide ROA
for Gensight Biologics SA.

Provide ROIC
for Gensight Biologics SA.

Provide ROCE
for Gensight Biologics SA.

Provide Gross Margin
for Gensight Biologics SA.

Provide Operating Margin
for Gensight Biologics SA.

Provide Net Margin
for Gensight Biologics SA.

Provide FCF Margin
for Gensight Biologics SA.

Show all solvency ratios
for Gensight Biologics SA.

Provide D/E Ratio
for Gensight Biologics SA.

Provide D/A Ratio
for Gensight Biologics SA.

Provide Interest Coverage Ratio
for Gensight Biologics SA.

Provide Altman Z-Score Ratio
for Gensight Biologics SA.

Provide Quick Ratio
for Gensight Biologics SA.

Provide Current Ratio
for Gensight Biologics SA.

Provide Cash Ratio
for Gensight Biologics SA.

What is the historical Revenue growth
over the last 5 years for Gensight Biologics SA?

What is the historical Net Income growth
over the last 5 years for Gensight Biologics SA?

What is the current Free Cash Flow
of Gensight Biologics SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Gensight Biologics SA.

SIGHT

Balance Sheet

Accrued Liabilities

Gensight Biologics SA
Accrued Liabilities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Gensight Biologics SA
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company		Accrued Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Gensight Biologics SA PAR:SIGHT	Accrued Liabilities €1.6m	CAGR 3-Years N/A	CAGR 5-Years -2%	CAGR 10-Years N/A
	Valneva SE PAR:VLA	Accrued Liabilities €41.5m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
G	Genfit SA PAR:GNFT	Accrued Liabilities €11k	CAGR 3-Years -86%	CAGR 5-Years -70%	CAGR 10-Years N/A
	Inventiva SA PAR:IVA	Accrued Liabilities €3.7m	CAGR 3-Years 17%	CAGR 5-Years 4%	CAGR 10-Years N/A
	Eurobio Scientific SA PAR:ALERS	Accrued Liabilities €6.1m	CAGR 3-Years 6%	CAGR 5-Years 13%	CAGR 10-Years 9%
	OSE Immunotherapeutics SA PAR:OSE	Accrued Liabilities €2.2m	CAGR 3-Years -7%	CAGR 5-Years 12%	CAGR 10-Years N/A

No Stocks Found

Gensight Biologics SA
Glance View

Market Cap

36.3m EUR

Industry

Biotechnology

GenSight Biologics SA is a clinical-stage gene therapy company. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2016-07-13. The firm develops and commercializes gene therapy-based treatments of retinal degenerative diseases. The company develops approaches to prevent retinal degeneration in selected pathological conditions and to restore vision in patients suffering from low vision or blindness. The firm intends notably to develop a gene replacement therapy for Leber's hereditary optic neuropathy (LHON) and an optogenetic therapy for retinitis pigmentosa (RP).

Open SIGHT Analysis

SIGHT Intrinsic Value

0.171 EUR

Overvaluation 46%

Intrinsic Value

Price

What is Intrinsic Value?

What is Gensight Biologics SA's Accrued Liabilities?

Accrued Liabilities
1.6m EUR

Based on the financial report for Jun 30, 2024, Gensight Biologics SA's Accrued Liabilities amounts to 1.6m EUR.

What is Gensight Biologics SA's Accrued Liabilities growth rate?

Accrued Liabilities CAGR 5Y
-2%

Over the last year, the Accrued Liabilities growth was -54%.

Gensight Biologics SA
PAR:SIGHT

Gensight Biologics SA
Accrued Liabilities

Gensight Biologics SA
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Gensight Biologics SA
Glance View

See Also

What is Gensight Biologics SA's Accrued Liabilities?

Accrued Liabilities
1.6m EUR

What is Gensight Biologics SA's Accrued Liabilities growth rate?

Accrued Liabilities CAGR 5Y
-2%

Company

Help

Tools

Stocks

Gensight Biologics SA PAR:SIGHT

Gensight Biologics SA Accrued Liabilities

Gensight Biologics SA Accrued Liabilities Peer Comparison

Competitors Analysis Latest Figures & CAGR of Competitors

Gensight Biologics SA Glance View

See Also

What is Gensight Biologics SA's Accrued Liabilities? Accrued Liabilities 1.6m EUR

What is Gensight Biologics SA's Accrued Liabilities growth rate? Accrued Liabilities CAGR 5Y -2%

Company

Help

Tools

Stocks

Gensight Biologics SA
PAR:SIGHT

Gensight Biologics SA
Accrued Liabilities

Gensight Biologics SA
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Gensight Biologics SA
Glance View

What is Gensight Biologics SA's Accrued Liabilities?

Accrued Liabilities
1.6m EUR

What is Gensight Biologics SA's Accrued Liabilities growth rate?

Accrued Liabilities CAGR 5Y
-2%